QUEBEC CITY, Sept. 4 /CNW/ - Medicago Inc. (TSX-V : MDG) (the "Company"),
today announced that it has granted 140,505 stock options to Andy Sheldon,
President and Chief Executive Officer and 83,169 to Louis P. Vézina, Chief
Scientific Officer, pursuant to the terms of their employment agreements and
conditions of the Company's stock option plan. These stock options were issued
at an exercise price of $0.37 and expire in five years.
